Moscow Multidisciplinary Clinical Center "Kommunarka"

Homepage: mmccdzm.ru

Alternate names: City Clinical Hospital No. 40, MMCC "Kommunarka", Государственное бюджетное учреждение здравоохранения города Москвы «Московский многопрофильный клинический центр «Коммунарка» Департамента здравоохранения города Москвы», Московский многопрофильный клинический центр «Коммунарка»

Related institution: Pirogov Russian National Research Medical University

ROR: 04wp5yq54

OpenAlex ID: I4405285160

Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial

2020 · Sebastian Grosicki, Maryana Simonova, et al. · The Lancet · 344

Enasidenib vs conventional care in older patients with late-stage mutant- IDH2 relapsed/refractory AML: a randomized phase 3 trial

2022 · Stéphane de Botton, Pau Montesinos, et al. · Blood · 129

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

2020 · Pau Montesinos, Gail J. Roboz, et al. · Leukemia · 106

Pharmacokinetic, Pharmacodynamic and Covariate Analysis of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma

2012 · Philippe Moreau, Ievgenii I. Karamanesht, et al. · Clinical Pharmacokinetics · 87

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

2022 · Fredrik H Schjesvold, Meletios-Athanasios Dimopoulos, et al. · The Lancet Haematology · 86

Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy

2023 · Alexandra Kavun, Egor Veselovsky, et al. · Cancers · 53

Cardiovascular complications of COVID-19

2020 · I. A. Kozlov, I. N. Tyurin · Messenger of Anesthesiology and Resuscitation · 48

Spectrum of TP53 Mutations in BRCA1/2 Associated High-Grade Serous Ovarian Cancer

2020 · Ulyana A. Boyarskikh, L. F. Gulyaeva, et al. · Frontiers in Oncology · 45

Septic shock in adults: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists”

2023 · M. Yu. Kirov, V. V. Kuzkov, et al. · Annals of critical care · 38

Incidence and prognostic factors in patents (pts) with mutant BRAF (mBRAF) metastatic colorectal cancer (mCRC) in Russia

2021 · M. Yu. Fedyanin, К M. Ehlsnukaeva, et al. · Meditsinskiy sovet = Medical Council · 36

Avascular Necrosis of the Femoral Head After COVID-19: A Case Series

2022 · Mikhail A. Panin, Armenak S. Petrosyan, et al. · Traumatology and Orthopedics of Russia · 35

Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

2023 · P. Hofman, F. Calabrese, et al. · ESMO Open · 34

Prediction of lethal outcomes in COVID-19 cases based on the results chest computed tomography

2020 · S. P. Morozov, V. A. Gombolevskiy, et al. · Tuberculosis and lung diseases · 32

The Role of Genetic Factors in the Development of Acute Respiratory Viral Infection COVID-19: Predicting Severe Course and Outcomes

2022 · Mikhail M. Minashkin, Nataliya Y. Grigortsevich, et al. · Biomedicines · 31

Clinical recommendations «Gestational diabetes mellitus» of the Russian Ministry of Health. Version of the year 2024

2025 · I. I. Dedov, N. G. Mokrysheva, et al. · Bulletin of Reproductive Health · 28

Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

2021 · Holger W. Auner, Maria Gavriatopoulou, et al. · American Journal of Hematology · 22

Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial

2022 · Meletios A. Dimopoulos, Fredrik Schjesvold, et al. · Blood Cancer Journal · 20

Influence of Surgical Trauma in the Nasal Cavity on the Expression of p53 Protein in the Hippocampus of Rats

2021 · I. V. Kastyro, I. V. Reshetov, et al. · Doklady Biochemistry and Biophysics · 19

The Use of Mesenchymal Stem Cells in the Complex Treatment of Kidney Tuberculosis (Experimental Study)

2022 · Alexander N. Muraviov, Tatiana I. Vinogradova, et al. · Biomedicines · 18

Analysis of Risk Factors in COVID-19 Adult Mortality in Russia

2021 · Youri Kirillov, Sergei Timofeev, et al. · Journal of Primary Care & Community Health · 18

A Comparative Cross-Sectional Study Assessing the Psycho-Emotional State of Intensive Care Units’ Physicians and Nurses of COVID-19 Hospitals of a Russian Metropolis

2022 · Artem Kashtanov, Ekaterina Molotok, et al. · International Journal of Environmental Research and Public Health · 17

Comparison of the Effects of Septoplasty and Sinus Lifting Simulation in Rats on Changes in Heart Rate Variability

2021 · S. G. Dragunova, I. V. Reshetov, et al. · Doklady Biochemistry and Biophysics · 17

Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study

2023 · Thomas Pabst, Cristina Papayannidis, et al. · The Lancet Haematology · 16

Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

2021 · Sosana Delimpasi, Maria Victoria Mateos, et al. · American Journal of Hematology · 15

Timing of surgery, intestinal ischemia and other real factors of mortality in acute adhesive small bowel obstruction: a multiple-center study

2021 · A.E. Tyagunov, A.A. Tyagunov, et al. · Pirogov Russian Journal of Surgery · 15

Works count: 574

Citation count: 3,284